What is Rivaroxaban ?

Rivaroxaban is an oral anticoagulant medication that selectively inhibits factor Xa, an essential component in the blood coagulation cascade, to effectively reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used for the prevention and treatment of deep vein thrombosis and pulmonary embolism, providing a convenient alternative to warfarin without the need for routine monitoring. Its predictable pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance.

• Bleeding
• Nausea
• Bruising easily
• Dizziness
• Headache
• Fatigue
• Abdominal pain
• Diarrhea
• Constipation
• Swelling in the extremities

• Increased risk of bleeding, which can be serious and potentially life-threatening
• Do not stop taking rivaroxaban without consulting your healthcare provider, as there is an increased risk of stroke
• Not recommended for patients with artificial heart valves
• Use with caution in patients with severe renal impairment
• Avoid using in conjunction with other medications that affect coagulation
• May cause liver enzyme abnormalities
• Pregnant or breastfeeding women should consult their healthcare provider before use
• Monitor for signs of bleeding, such as unusual bruising, dark stools, or bloody urine
• Surgery or invasive procedures may require temporary discontinuation of the medication
• Patients with a history of hypersensitivity to the drug should not use it